Abstract:OBJECTIVE:To assess the mechanism of exacerbation of colonic damage in rat colitis model induced by trinitrobenzene sulfonic acid (TNBS) treated with celecoxib (a selective COX-2 inhibitor). METHODS:The rats were randomized into four groups. Group 1 and Group 2 were study groups. Group 3 and Group 4 were control groups. Colitis was induced by intracolonic administration of TNBS (25 g/L) in a vehicle of 50% ethanol (0.25 mL) of study groups. The rats of study groups were treated orally, beginning 3 h before induction of colitis and continuing twice per day thereafter for up to 7 d, with celecoxib (1.25 mg/kg, Group 1) and distilled water (1 mL/0.3 kg, Group 2) respectively. In control experiments, the rats of Group 4 were treated orally with celecoxib (1.25 mg/kg) twice per day for up to 7 d. Group 3 rats were healthy control rats. All the rats that survived until the end of the experiment (d 7) were killed and the severity of colonic inflammation was assessed. The COX-2 protein expression in colon tissues was examined by immunohistochemistry. RESULTS:The colonic damage of Group 1 was exacerbated as compared with Group 2. The inflammatory index of colon tissues of Group 1 (8.5+/-2.5) was significantly reduced, as compared with Group 2 (13.5+/-1.9, P<0.05). The levels of COX-2 protein expression was decreased significantly in Group 1 (3.7 x 10(-2)+/-9.5 x 10(-3)) as compared with Group 2 (11.4 x 10(-2)+/-3.8 x 10(-2), P<0.05). The positive rate of COX-2 expression in neural cells of the myenteric plexus in Group 1 (30%) was decreased as compared with Group 2 (90%, P<0.05). No difference was found in the inflammatory index, the levels of COX-2 protein expression and the positive rate of COX-2 expression in neural cells of the myenteric plexus of Group 3 and Group 4. CONCLUSION:Selective COX-2 inhibitor-celecoxib could decrease the expression of COX-2 in intestinal tissue, attenuate the inflammatory index of colon tissues of experimental colitis induced by TNBS. But the application of celecoxib resulted in exacerbation of colonic damage. These adverse events are probably relevant to the suppression of COX-2 expression in the neural cells of the myenteric plexus, leading to decrease of intestinal contractivity and peristalsis, enteroparalysis, megacolon and death of the rat.

Celecoxib Alleviates Radiation-Induced Brain Injury in Rats by Maintaining the Integrity of Blood-Brain Barrier

The Effects of Celecoxib on Human Brain Microvascular Endothelial Cells Release 6-Keto-pgf1α and TXB2 and Apoptosis after Radiation

Celecoxib in the Histological Grade of Chemically Induced Mammary Tumor in Rats

Effect of celecoxib on hepatic and renal functions in rats with mammary carcinoma

Celecoxib reduces skin damage after radiation: selective reduction of chemokine and receptor mRNA expression in irradiated skin but not in irradiated mammary tumor

Celecoxib Enhances the Sensitivity of Non-Small-cell Lung Cancer Cells to Radiation-Induced Apoptosis Through Downregulation of the Akt/mTOR Signaling Pathway and COX-2 Expression

Celecoxib Radiosensitizes the Human Cervical Cancer HeLa Cell Line Via a Mechanism Dependent on Reduced Cyclo-Oxygenase-2 and Vascular Endothelial Growth Factor C Expression

Celecoxib Enhances the Radiosensitivity of HCT116 Cells in a COX-2 Independent Manner by Up-Regulating BCCIP.

Radiosensitizing Effects of COX-2 Inhibitor Celecoxib on the Five Different Human Malignent Cell Lines

Study of the mechanism of radiation sensitizing effect of celecoxib on breast cancer cells with different estrogen receptors status

Effects and mechanism of the selective COX-2 inhibitor, celecoxib, on rat colitis induced by trinitrobenzene sulfonic acid

Celecoxib Enhances Radiosensitivity Via Induction of G2-M Phase Arrest and Apoptosis in Nasopharyngeal Carcinoma

Neuroprotective effect of resveratrol against radiation after surgically induced brain injury by reducing oxidative stress, inflammation, and apoptosis through NRf2/HO‐1/NF‐κB signaling pathway

Celecoxib's Radiosensitizing Effects on Three Different Human Cancer Cell Lines

Celecoxib treatment alleviates cerebral injury in a rat model of post-traumatic epilepsy

Radiosensitization of Celecoxib on Human Lung Adenocarcinoma Cell Line A549 and Inhibition of Migration Ability in Vitro

Inhibition of Cyclooxygenase‑2 Sensitizes Lung Cancer Cells to Radiation‑induced Apoptosis

Study on Enhancement of Radiosensitivity in Colon Cancer Carcinoma Cell Line HT-29 by Celecoxib in Vitro and in Vivo

Effect of Inhibiting Cyclooxygenase-2 Expression on Glioma Immune Microenvironment and Biological Behavior

[Mechanism of exacerbation of colonic damage in experimental colitis treated with celecoxib].

Radiosensitizing Effect of Celecoxib on Human Pancreatic Carcinoma